Organization · Venture Capital
Qbic Fund | Venture Capital
Qbic Fund is a seed and early-stage venture capital fund based in St-Denijs-Westrem, Belgium, focusing on transforming university research into sustainable businesses. It is one of Europe's largest spin-off funds, managing approximately €190 million across three funds.
Overview
What Qbic Fund | Venture Capital does
What Qbic Fund | Venture Capital is
Qbic Fund is a seed and early-stage venture capital fund based in St-Denijs-Westrem, Belgium, focusing on transforming university research into sustainable businesses. It is one of Europe's largest spin-off funds, managing approximately €190 million across three funds.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2012
- Approximate age
- About 14 years
- Structured capabilities
- Funder
- Last reviewed
- March 30, 2026
Official channels
Find Qbic Fund | Venture Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Qbic Fund | Venture Capital as a funder
Investment thesis
Qbic Fund invests in seed and early-stage spin-offs and startups that valorize research from its knowledge partners, focusing on transforming technological breakthroughs into sustainable businesses.
Focus narrative
Qbic Fund is a sector-agnostic seed and early-stage venture capital fund that typically participates in the first external investment round of companies. It invests in two main categories: knowledge partner spin-offs and startups linked to knowledge partners, emphasizing strong R&D collaborations.
Value beyond capital
Qbic Fund provides active support to its portfolio companies, engaging in pre-investment coaching 12-18 months before incorporation. This collaborative approach with knowledge partners enhances the growth potential of the startups and spin-offs it invests in.
Terms and economics
- Typical check
- $100,000–$2,000,000
- Sweet spot
- $500,000
Focus and fit
- Stages
- Seed · Seed+ · Series A
- Sectors
- Biotech & Life Sciences
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 38
- Recorded notable exits
- Biotalys, PharmaFluidics, Multiplicom, Biogazelle, and Molecubes
Portfolio context
Notable portfolio companies include: AILOS: Redefining actuation for next-generation robotics. Innocens: Developing AI-powered alerts for patient deterioration. Spica Therapeutics: Pioneering macrophage-subset targeted therapies. eyeo: Developing breakthrough color-splitting photonics for high-performance imaging. Rainbow Crops: Combining genome editing and precision breeding for climate-resilient crops. Pleevi: Providing AI-driven smart charging solutions for electric vehicles. Tanai Therapeutics: Developing an oral therapeutic for obesity. Flindr: Aiming to restore immune response to cancer. VoxelSensors: Developing ultra-low power 3D perception sensors for Extended Reality. Animab: Developing antibodies for gastrointestinal pathogens in livestock.
Common questions
What to know about Qbic Fund | Venture Capital
Upseed classifies Qbic Fund | Venture Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.